Mild fasting hyperglycemia shifts fuel reliance toward fat during exercise in adults with impaired glucose tolerance

Journal of Applied Physiology

Volumn 115, Issue 1, 2013, Pages 78-83

  Malin, Steven K ^a   Viskochil, Richard ^a   Oliver, Corianne ^a   Braun, Barry ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Diabetes; Hyperglycemia; Metabolic flexibility; Prediabetes

Indexed keywords

FATTY ACID; GLUCOSE; GLYCOGEN; INSULIN;

ADULT; ANAEROBIC THRESHOLD; ANTHROPOMETRY; ARTICLE; BLOOD; BLOOD ANALYSIS; CALORIMETRY; DIABETES MELLITUS; DIET RESTRICTION; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIPID METABOLISM; MALE; METABOLIC FLEXIBILITY; METABOLISM; MIDDLE AGED; OXYGEN CONSUMPTION; PHYSIOLOGY;

DIABETES; HYPERGLYCEMIA; METABOLIC FLEXIBILITY; PREDIABETES;

ADULT; ANAEROBIC THRESHOLD; ANTHROPOMETRY; BLOOD CHEMICAL ANALYSIS; BLOOD GLUCOSE; CALORIMETRY, INDIRECT; EXERCISE; FASTING; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; GLYCOGEN; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MIDDLE AGED; OXYGEN CONSUMPTION;

EID: 84880074582     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00084.2013     Document Type: Article

References (40)

1. Aas V, Hessvik N, Wettergreen M, Hvammen A, Hallen S, Thoresen GH, Rustan A. Chronic hyperglycemia reduces substrate oxidation and impairs metabolic switching of human myotubes. Biochim Biophys Acta 1812: 94-105, 2011.
2. Blake DR, Meigs JB, Muller DC, Najjar SS, Andres R, Nathan DM. Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging. Diabetes 53: 2095-2100, 2004.
3. Bock G, Dalla Man C, Campioni M, Chittilapilly E, Basu R, Toffolo G, Cobelli C, Rizza R. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 55: 3536-3549, 2006.
4. Borghouts LB, Wagenmakers AJ, Goyens PL, Keizer HA. Substrate utilization in non-obese Type II diabetic patients at rest and during exercise. Clin Sci (Lond) 103: 559-569, 2002.
5. Braun B, Sharoff CG, Chipkin SR, Beaudoin F. Effects of insulin resistance on substrate utilization during exercise in overweight women. J Appl Physiol 97: 991-997, 2004.
6. Colberg SR, Hagberg JM, McCole SD, Zmuda JM, Thompson PD, Kelley DE. Utilization of glycogen but not plasma glucose is reduced in individuals with NIDDM during mild-intensity exercise. J Appl Physiol 81: 2027-2033, 1996.
7. Constantin-Teodosiu D, Constantin D, Stephens F, Laithwaite D, Greenhaff PL. The role of FOXO and PPAR transcription factors in diet-mediated inhibition of PDC activation and carbohydrate oxidation during exercise in humans and the role of pharmacological activation of PDC in overriding these changes. Diabetes 61: 1017-1024, 2012.
8. Cusi KJ, Pratipanawatr T, Koval J, Printz R, Ardehali H, Granner DK, Defronzo RA, Mandarino LJ. Exercise increases hexokinase II mRNA, but not activity in obesity and type 2 diabetes. Metabolism 50: 602-606, 2001.
9. Faerch K, Vaag A. Metabolic inflexibility is a common feature of impaired fasting glycaemia and impaired glucose tolerance. Acta Diabetol 48: 349-353, 2011.
10. Festa A, D'Agostino R, Howard G, Mykknen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102: 42-47, 2000.
11. Galgani J, Moro C, Ravussin E. Metabolic flexibility and insulin resistance. Am J Physiol Endocrinol Metab 295: E1009-E1017, 2008.
12. Goodpaster BH, He J, Watkins S, Kelley DE. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 86: 5755-5761, 2001.
13. Goodpaster BH, Wolfe RR, Kelley DE. Effects of obesity on substrate utilization during exercise. Obes Res 10: 575-584, 2002.
14. Goodpaster B, Coen P. Do acute exercise and diet reveal the molecular basis for metabolic flexibility in skeletal muscle? Diabetes 61: 983-983, 2012.
15. Haffner SM. Insulin resistance, inflammation, and the prediabetic state. Am J Cardiol 92: 18J-26J, 2003.
16. Hernandez-Alvarez MI, Thabit H, Burns N, Shah S, Brema I, Hatunic M, Finucane F, Liesa M, Chiellini C, Naon D, Zorzano A, Nolan JJ. Subjects with early-onset type 2 diabetes show defective activation of the skeletal muscle PGC-1 /mitofusin-2 regulatory pathway in response to physical activity. Diabetes Care 33: 645-651, 2010.
17. Holloway GP, Bonen A, Spriet LL. Regulation of skeletal muscle mitochondrial fatty acid metabolism in lean and obese individuals. Am J Clin Nutr 89: 455S-462S, 2009.
18. Horowitz JF, Klein S. Oxidation of nonplasma fatty acids during exercise is increased in women with abdominal obesity. J Appl Physiol 89: 2276-2282, 2000.
19. Houmard JA. Intramuscular lipid oxidation and obesity. Am J Physiol Regul Integr Comp Physiol 294: R1111-R1116, 2008.
20. Kanaley JA, Cryer PE, Jensen MD. Fatty acid kinetic responses to exercise. Effects of obesity, body fat distribution, and energy-restricted diet. J Clin Invest 92: 255-261, 1993.
21. Kang J, Kelley DE, Robertson RJ, Goss FL, Suminski RR, Utter AC, Dasilva SG. Substrate utilization and glucose turnover during exercise of varying intensities in individuals with NIDDM. Med Sci Sports Exerc 31: 82-89, 1999.
22. Kelley DE, Mokan M, Simoneau JA, Mandarino LJ. Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 92: 91-98, 1993.
23. Kelley DE, Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49: 677-683, 2000.
24. Kulkarni SS, Salehzadeh F, Fritz T, Zierath JR, Krook A, Osler ME. Mitochondrial regulators of fatty acid metabolism reflect metabolic dysfunction in type 2 diabetes mellitus. Metabolism 61: 175-185, 2012.
25. Malin SK, Stephens BR, Sharoff CG, Hagobian TA, Chipkin SR, Braun B. Metformin's effect on exercise and postexercise substrate oxidation. Int J Sport Nutr Exerc Metab 20: 63-71, 2010.
26. Malin SK, Kirwan JP. Fasting hyperglycaemia blunts the reversal of impaired glucose tolerance after exercise training in obese older adults. Diabetes Obes Metab 14: 835-841, 2012.
27. Malin SK, Gerber R, Chipkin SR, Braun B. Independent and combined effects of exercise training and metformin on insulin sensitivity in individuals with prediabetes. Diabetes Care 35: 131-136, 2012.
28. Mensink M, Blaak EE, van Baak MA, Wagenmakers AJ, Saris WH. Plasma free fatty acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes. Diabetes 50: 2548-2554, 2001.
29. Muoio DM, Neufer PD. Lipid-induced mitochondrial stress and insulin action in muscle. Cell Metab 15: 595-605, 2012.
30. Peronnet F, Massicotte D. Table of nonprotein respiratory quotient: an update. Can J Sport Sci 16: 23-29, 1991.
31. Perreault L, Bergman BC, Hunerdosse DM, Playdon MC, Eckel RH. Inflexibility in intramuscular triglyceride fractional synthesis distinguishes prediabetes from obesity in humans. Obesity (Silver Spring) 18: 1524-1531, 2010.
32. Perreault L, Bergman BC, Playdon MM, Dalla Man C, Cobelli C, Eckel RH. Impaired fasting glucose with or without impaired glucose tolerance: progressive or parallel states of prediabetes? Am J Physiol Endocrinol Metab 295: E428-E435, 2008.
33. Raboll R, Hojberg PM, Almdal T, Boushel R, Haugaard SB, Madsbad S, Dela F. Effect of hyperglycemia on mitochondrial respiration in type 2 diabetes. J Clin Endocrinol Metab 94: 1372-1378, 2009.
34. Rizza R. Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy. Diabetes 59: 2697-2707, 2010.
35. Sharoff CG, Hagobian TA, Malin SK, Chipkin SR, Yu H, Hirshman MF, Goodyear LJ, Braun B. Combining short-term metformin treatment and one bout of exercise does not increase insulin action in insulin resistant individuals. Am J Physiol Endocrinol Metab 298: E815-E823, 2010.
36. Sherman WM, Costill DL, Fink WJ, Miller JM. Effect of exercise-diet manipulation on muscle glycogen and its subsequent utilization during performance. Int J Sports Med 2: 114-118, 1981.
37. Thyfault JP, Kraus RM, Hickner RC, Howell AW, Wolfe RR, Dohm GL. Impaired plasma fatty acid oxidation in extremely obese women. Am J Physiol Endocrinol Metab 287: E1076-E1081, 2004.
38. van de Weijer T, Sparks L, Phielix E, Meex R, van Herpen N, Hesselink MKC, Schrauwen P, Schrauwen Hinderling V. Relationships between mitochondrial function and metabolic flexibility in type 2 diabetes mellitus. PLos One 8: e51648-e51648, 2013.
39. Weyer C, Bogardus C, Pratley RE. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 48: 2197-2203, 1999.
40. Wolfe RR. Radioactive and Stable Isotope Tracers in Biomedicine. New York: Wiley-Liss, 1992, p. 119-144. Diseases